PNPriyanka S. Narayan

Priyanka S. Narayan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Priyanka S. Narayan has a total of 111 co-authors. Here are the top co-authors by number of shared publications:

  • Jessica T. Root

    Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, USA

    3 shared publications
  • Linda G. Yang

    Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD USA

    3 shared publications
  • Carla Cuní-López

    Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, USA

    2 shared publications
  • Jaanam Gopalakrishnan

    National Eye Institute, National Institutes of Health, Bethesda, MD, USA

    2 shared publications
  • Kory R. Johnson

    National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA

    2 shared publications
  • Linda G. Yang

    Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, USA

    2 shared publications

Latest Publications

  • Open Access

    APOE genotypes differentially remodel the astrocytic lipid droplet proteome to shape lipid droplet dynamics

    by Carla Cuní-López, Jessica T. Root, Ying Hao, Niek Blomberg, Sascha J. Koppes-Den Hertog, Dylan Sacks, Amber E. Trujillo, Rodolfo Ghirlando, Isabelle Kowal, Jacob Epstein, et al.

    Lipid droplets are dynamic cellular organelles that store neutral lipids and coordinate metabolic and stress-response pathways. In the brain, lipid droplets in glial cells, including astrocytes, have been implicated in Alzheimer’s disease, but how genetic risk factors influence their composition and turnover remains poorly understood. APOE is the strongest genetic modulator of late-onset Alzheimer’s disease and exists in common variants that confer decreased, neutral, or increased risk. Here we show that APOE genotype shapes the lipid droplet proteome, lipidome, and degradation dynamics in human induced pluripotent stem cell-derived astrocytes. By comparing oleic acid-treated astrocytes carrying APOE2 , APOE3 , or APOE4 , we find that each variant is associated with distinct lipid droplet proteins and lipids. These molecular differences correspond to genotype-dependent changes in lipophagy, an autophagy-mediated pathway for lipid droplet clearance. Lipid droplets in APOE2 astrocytes undergo efficient autophagic turnover, whereas those in APOE4 astrocytes resist degradation. These findings identify impaired lipid droplet clearance as a potential mechanism linking APOE4 to Alzheimer’s disease risk.


  • Open Access

    APOE4 and INPP5D converge on membrane mechanics to regulate endocytosis in human astrocytes

    by Artur S. Gevorgyan, Lila M. Gordon, Christian A. Combs, Adrian Lita, Linda G. Yang, Carla Cuní-López, Jessica T. Root, Mioara Larion, Justin W. Taraska, Priyanka S. Narayan

    Disrupted endocytosis is an early feature of Alzheimer’s disease (AD), but how genetic risk factors functionally impact this pathway remains unclear. Using isogenic human iPSC-derived astrocytes, we show that the AD risk variant, APOE4, impairs clathrin-mediated membrane curvature, clathrin-mediated endocytosis, and alters plasma membrane lipid saturation and tension. Compared to APOE3 astrocytes, APOE4 cells display an accumulation of flat clathrin structures, reduced maturation of clathrin-coated pits, decreased early endosomes, and reduced endocytic uptake. We then identify the AD risk gene INPP5D as a modifier that restores early endocytosis in APOE4 astrocytes by promoting clathrin curvature and maturation through a mechanism distinct from membrane tension regulation. Beyond effects on trafficking, INPP5D overexpression also reduces lipid droplet accumulation and attenuates inflammatory signaling, linking membrane dynamics to disease-associated astrocytic phenotypes. Together, these findings establish altered membrane mechanics as a proximal consequence of the APOE4 variant and identify endocytosis as a common node linking AD risk genes.

  • Top Cited Papers
    Open Access

    Triglyceride metabolism controls inflammation and microglial phenotypes associated with APOE4

    by Roxan A. Stephenson, Jordy Sepulveda, Kory R. Johnson, Adrian Lita, Jaanam Gopalakrishnan, Dominic J. Acri, Alexandra Beilina, Linling Cheng, Linda G. Yang, Jessica T. Root, et al.


  • Time for lipid cell biology

    by Xiao-Wei Chen, Anthony S. Don, Maria Fedorova, Takeshi Harayama, Natalie Krahmer, Shigekazu Nagata, Priyanka Narayan, Dequina Nicholas, Sara M. Nowinski, Yasunori Saheki, et al.


  • Open Access

    ProtPipe: A Multifunctional Data Analysis Pipeline for Proteomics and Peptidomics

    by Ziyi Li, Cory A Weller, Syed Shah, Nicholas L Johnson, Ying Hao, Paige B Jarreau, Jessica Roberts, Deyaan Guha, Colleen Bereda, Sydney Klaisner, et al.

    Mass spectrometry (MS) is a technique widely employed for the identification and characterization of proteins, with personalized medicine, systems biology, and biomedical applications. The application of MS-based proteomics advances our understanding of protein function, cellular signaling, and complex biological systems. MS data analysis is a critical process that includes identifying and quantifying proteins and peptides and then exploring their biological functions in downstream analyses. To address the complexities associated with MS data analysis, we developed ProtPipe to streamline and automate the processing and analysis of high-throughput proteomics and peptidomics datasets with DIA-NN preinstalled. The pipeline facilitates data quality control, sample filtering, and normalization, ensuring robust and reliable downstream analyses. ProtPipe provides downstream analyses, including protein and peptide differential abundance identification, pathway enrichment analysis, protein–protein interaction analysis, and major histocompatibility complex (MHC)–peptide binding affinity analysis. ProtPipe generates annotated tables and visualizations by performing statistical post-processing and calculating fold changes between predefined pairwise conditions in an experimental design. It is an open-source, well-documented tool available at https://github.com/NIH-CARD/ProtPipe, with a user-friendly web interface.


  • Open Access

    Triglyceride metabolism controls inflammation and APOE4 -associated disease states in microglia

    by Roxan A. Stephenson, Kory R. Johnson, Linling Cheng, Linda G. Yang, Jessica T. Root, Jaanam Gopalakrishnan, Han-Yu Shih, Priyanka S. Narayan

    Microglia modulate their cell state in response to various stimuli. Changes to cellular lipids often accompany shifts in microglial cell state, but the functional significance of these metabolic changes remains poorly understood. In human induced pluripotent stem cell-derived microglia, we observed that both extrinsic activation (by lipopolysaccharide treatment) and intrinsic triggers (the Alzheimer’s disease-associated APOE4 genotype) result in accumulation of triglyceride-rich lipid droplets. We demonstrate that lipid droplet accumulation is not simply concomitant with changes in cell state but rather necessary for microglial activation. We discovered that both triglyceride biosynthesis and catabolism are needed for the transcription and secretion of proinflammatory cytokines and chemokines in response to extrinsic stimuli. Additionally, we reveal that triglyceride biosynthesis and catabolism are necessary for the activation-associated phagocytosis of multiple substrates including the disease-associated amyloid-beta peptide. In microglia harboring the Alzheimer’s disease risk APOE4 genotype, triglyceride-rich lipid droplets accumulate even in the absence of any external stimuli. Inhibiting triglyceride biosynthesis in APOE4 microglia not only modifies the transcription of immune response genes but also attenuates disease-associated transcriptional states. This work establishes that triglyceride metabolism is necessary for microglia to respond to extrinsic activation. In APOE4 microglia, this metabolic process modulates both immune signaling and a disease-associated transcriptional state. Importantly, our work identifies metabolic pathways that can be used to tune microglial immunometabolism in APOE4- associated disease.


  • Harnessing diversity to study Alzheimer’s disease: A new iPSC resource from the NIH CARD and ADNI

    by Laurel A. Screven, Caroline B. Pantazis, Katherine M. Andersh, Samantha Hong, Dan Vitale, Erika Lara, Ray Yueh Ku, Peter Heutink, Jason Meyer, Kelley Faber, et al.


  • Top Cited Papers
    Open Access

    Apolipoprotein E in lipid metabolism and neurodegenerative disease

    by Linda G. Yang, Zachary M. March, Roxan A. Stephenson, Priyanka S. Narayan


  • Discovering and reversing the metabolic consequences of APOE4 in iPSC-derived glia

    by Priyanka Narayan

    A coding point mutation in the Apolipoprotein E gene (called APOE4), a lipoprotein involved in lipid transport and metabolism, greatly increases the risk for a number of neurodegenerative diseases, most notably sporadic Alzheimer’s disease. Although the relationship between APOE4 and age-associated diseases is firmly established, it remains unclear how APOE4 acts on a cellular

  • Top Cited Papers

    APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia

    by Grzegorz Sienski, Priyanka Narayan, Julia Maeve Bonner, Nora Kory, Sebastian Boland, Aleksandra A. Arczewska, William T. Ralvenius, Leyla Akay, Elana Lockshin, Liang He, et al.

    APOE4 -disrupted intracellular lipid homeostasis in human and yeast cells was reversed by promoting phospholipid synthesis through choline supplementation.